Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Mbzt, CC BY-SA 4.0, Wikimedia Commons
Vous êtes Dr Thomas Funck-Brentano ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Thomas Funck-Brentano est rhumatologue à Paris 12e (75012). Il consulte notamment à SERVICE DE SOINS PARIS GARE DE LYON, 41 Rue DU CHAROLAIS, 75012 Paris 12e Arrondissement (2 lieux au total).
Consulter
SERVICE DE SOINS PARIS GARE DE LYON
41 Rue DU CHAROLAIS, 75012 Paris 12e Arrondissement
Hospitalier
Dr Thomas Funck-Brentano, c'est vous ?
Faites de cette fiche la page de votre cabinet.
GHU APHP NUP SITE LARIBOISIERE
2 Rue AMBROISE PARE, 75475 Paris 10e Arrondissement
Hospitalier
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Bureau exécutif GRIO · GRIO
Les plus citées
2017Annals of the rheumatic diseases300 citations
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
2019Arthritis & rheumatology (Hoboken, N.J.)169 citations
Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank
2014Arthritis & rheumatology (Hoboken, N.J.)108 citations
Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice
En bref
Dr Thomas Funck-Brentano exerce dans 2 lieux : SERVICE DE SOINS PARIS GARE DE LYON, 41 Rue DU CHAROLAIS, 75012 Paris 12e Arrondissement et GHU APHP NUP SITE LARIBOISIERE, 2 Rue AMBROISE PARE, 75475 Paris 10e Arrondissement. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 71 21 48 94 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Paris 12e, j'accompagne…
Exemple : vous choisissez vos propres domaines.
2026Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchPubMed
Impaired organic and mineral extracellular matrix composition in early-onset osteoporosis
2024Calcified tissue internationalPubMed
Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene
2024The American journal of gastroenterologyPubMed
Osteoporosis and Fragility Fractures in Patients With Cirrhosis Evaluated for Liver Transplantation: Identification of High-Risk Patients Based on Computed Tomography at Evaluation
2023JBMR plusPubMed
Lrp5 p.Val667Met Variant Compromises Bone Mineral Density and Matrix Properties in Osteoporosis
2023RMD openPubMed
Patients with osteoporosis: children of a lesser god
2021Molecular genetics & genomic medicinePubMed
More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A
2020Journal of clinical medicinePubMed
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
2018JBMR plusPubMed
Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes
2020Calcified tissue internationalPubMed
Wnt16 Overexpression in Osteoblasts Increases the Subchondral Bone Mass but has no Impact on Osteoarthritis in Young Adult Female Mice
2019Arthritis & rheumatology (Hoboken, N.J.)PubMed
Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank
2018Scientific reportsPubMed
Proprotein convertase furin inhibits matrix metalloproteinase 13 in a TGFβ-dependent manner and limits osteoarthritis in mice
2017Annals of the rheumatic diseasesPubMed
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
2015Current opinion in rheumatologyPubMed
Subchondral bone and osteoarthritis
2015Arthritis research & therapyPubMed
Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways
2014Arthritis & rheumatology (Hoboken, N.J.)PubMed
Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice
2025The Journal of clinical endocrinology and metabolismPubMed
Genetics and Bone Mineral Density Predict the Fractures in Adults With Osteogenesis Imperfecta: A Prospective Study
2024European journal of medical geneticsPubMed
Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND
2023Nature geneticsPubMed
An atlas of genetic determinants of forearm fracture
2022Cell reports. MedicinePubMed
Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study
2018Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchPubMed
Genetic and Molecular Insights Into Genotype-Phenotype Relationships in Osteopathia Striata With Cranial Sclerosis (OSCS) Through the Analysis of Novel Mouse Wtx Mutant Alleles
2026Lancet (London, England)PubMed
Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial
2023JCI insightPubMed
Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations
2023Nature medicinePubMed
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
2025 · Article
Letter to the Editor: More on bone microarchitecture and volumetric BMD in men and women with PLS3 gene variants assessed with HR-pQCT
2025 · Article
Impaired organic and mineral extracellular matrix composition in early-onset osteoporosis
2024 · Article
Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene
2023 · Article
Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations
2023 · Article
Lrp5 p. Val667Met Variant Compromises Bone Mineral Density and Matrix Properties in Osteoporosis
2023 · Article
Patients with osteoporosis: children of a lesser god
2021 · Article
More severe phenotype of early‐onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A
2021 · Article
Inadequate response to treatment reveals persistent osteoclast bone resorption in osteoporotic patients
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.